Cambridge Healthtech Institute’s Sixth Annual  

Global Site Selection, Feasibility Assessment, Operations and Site Management: 

Improving Outcomes through Strategy, Relationships, Data and Execution
February 23-24, 2016 | Hyatt Regency Miami | Miami, FL  


 

Dear Colleague:

I am pleased to announce production of CHI’s 6th Annual Global Site Selection, Feasibility Assessment, Operations and Site Managementbeing held February 23-24, 2016 at the Hyatt Regency in Miami, FL. 

The gathering will be part of the 7th Annual Summit for Clinical Trials Operations Executives (SCOPE), a three-day cluster of events that attracted 900 leaders in clinical operations and research in February 2015. Topics to be discussed at the Annual Global Site Selection, Feasibility Assessment, Operations and Site Managementconference include:

  • Analyzing the market: Working with stakeholders early on to better identify the patient segment and improve protocol feasibility and planning
  • Employing trial design and protocol development strategies that support study site compliance: Minimize downstream operational challenges with good design
  • Site selection and study planning considerations: Understanding regional issues, regulatory landscapes, and local ethics processes
  • Optimizing country selection: Strategies for positioning trials for success using a global footprint
  • Optimizing the site feasibility process: Improving global site feasibility assessment to identify sites that will recruit on time and within budget
  • Understanding your protocol and its burden on your clinical ops teams, sites and patients: Decide on patient cohort  and strategy early prior to going into tactics
  • Objective country feasibility and selection: Where are the patients?
  • Data-driven site selection: Understand the number of sites, their probability of success, and the impact of site non-performance
  • Cost-effective techniques for finding high performing sites: High-tech and low-tech solutions to avoid uninterested and low enrolling parties
  • Overcoming challenges in clinical operations and site management: Linking sponsors, service providers and investigative sites and positioning sites for success by anticipating their needs
  • Improving operational efficiencies in Site, CRO, and Sponsor Interactions: Implementing Strategic Relationships and other forms of partnerships
  • Driving innovation in study start-up: Optimizing processes, training leaders and leveraging technology
  • Update on TransCelerate and other industry collaborations
  • Leveraging EMRs/EHRs to improve feasibility and recruitment

If you are interested in presenting, please submit a speaking proposal for review.

Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academic /hospital centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Deadline for submission is June 26, 2015.


Click on Image
 

SCOPE 2015 Wrap-Up 

Held February 24-26, 2015, in Orlando, Florida, the 6th Annual SCOPE Summit gathered more than 900 industry leaders, an attendance increase of 30% from 2014, for three stimulating days of in-depth discussions covering important issues in clinical trial planning and management. With 12 different conference tracks, a Clinical Informatics News Best Practices Awards and three plenary keynote sessions, SCOPE offered advances and innovative solutions in all aspects of clinical trial management and operations, including Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Forecasting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, and Pharmacovigilance. The impressive executive audience at SCOPE came together for invaluable networking opportunities with more than 70% of the attendees titled as Executives from leading Pharma (24%), CRO (31%), and Biotech companies (20%). Industry leaders and key decision makers representing 13 different countries and more than 360 unique organizations shared case studies, collaborated on best practices and provided unique perspectives on poignant issues that the field currently faces.

For Further Information 

For questions or suggestions about the meeting, please contact:

Micah Lieberman
Executive Director, Conferences
Cambridge Healthtech Institute (CHI)
T: (+1) 541.482.4709
E: mlieberman@healthtech.com 

For partnering and sponsorship information, please contact:

Ilana Quigley
Manager, Business Development
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5457
E: iquigley@healthtech.com  

For media and association partnerships, please contact:

Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5456
E: rhandy@healthtech.com 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  



 

 Scope 2015 CAG Icon 

Submit a Speaking Proposal  

 

> Premier Sponsors 

 BBK 

 ClinicalInk 

Drug Dev

 IMS Health   

PRA Health Sciences 

QUINTILES
 

> View All Sponsors 

> View Media Partners 

> View Attendee List 

> Attendee Profile